Secukinumab-Induced Alopecia Areata Successfully Treated with Tofacitinib in a Patient with Palmoplantar Pustulosis

Secukinumab, a monoclonal antibody targeting interleukin-17 (IL-17), has exhibited encouraging results in the therapeutic management of palmoplantar pustulosis (PPP). The development of alopecia areata (AA) is closely related to IL-17, and IL-17A inhibitors were considered as a potential treatment m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chen, Kang, Tianlun, Qian, Tangliang, Ma, Mingwei, Hou, Xiujuan, Li, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588803/
https://www.ncbi.nlm.nih.gov/pubmed/37869531
http://dx.doi.org/10.2147/CCID.S430156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588803/
https://www.ncbi.nlm.nih.gov/pubmed/37869531
http://dx.doi.org/10.2147/CCID.S430156

Ejemplares similares